Postexposure Prophylaxis

Updated guidelines for antiretroviral postexposure prophylaxis after sexual, injection drug use, or other nonoccupational exposure to HIV—United States, 2016

  • Source: US Department of Health and Human Services and Centers for Disease Control and Prevention

  • Publication Date: 4/18/16

Updated US Public Health Service Guidelines for the Management of Occupational Exposures to Human Immunodeficiency Virus and Recommendations for Postexposure Prophylaxis

  • Source: US Public Health Service and Centers for Disease Control and Prevention

  • Publication Date: 8/7/13

UPDATE: HIV Prophylaxis Following Non-Occupational Exposure

  • Source: New York State Department of Health AIDS Institute and Johns Hopkins University Division of Infectious Diseases

  • Publication Date: 7/1/13

UK guideline for the use of post-exposure prophylaxis for HIV following sexual exposure

  • Source: British Association for Sexual Health and HIV

  • Publication Date: 12/1/12

UPDATE: HIV Prophylaxis Following Occupational Exposure

  • Source: New York State Department of Health AIDS Institute

  • Publication Date: 10/1/12

Post-Exposure Prophylaxis to Prevent HIV Infection

  • Source: World Health Organization and International Labour Organization

  • Publication Date: 3/19/07

Offering HIV Post-Exposure Prophylaxis (PEP) Following Nonoccupational Exposures Recommendations for Health Care

  • Source: The California Task Force on Nonoccupational PEPand the California Department of Health Services, Office of AIDS

  • Publication Date: 6/1/04

Proposed Recommendations for the Management of HIV Post-Exposure Prophylaxis After Sexual, Injecting Drug or Other Exposures in Europe

  • Source: Euro-NONOPEP Project group

  • Publication Date: 6/1/04

Towards a Standard HIV Post-Exposure Prophylaxis for Healthcare Workers in Europe

  • Source: European Occupational Post-Exposure Prophylaxis Study Group

  • Publication Date: 6/1/04

©2020 Clinical Care Options, LLC. All Rights Reserved.

The materials published via inPractice® reflect the views of the reviewers or authors of the material, not those of Clinical Care Options, LLC, the accredited provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.